Zhao, Z., Pei, Z., Hu, A., Zhang, Y
The first animal studies showing that GLP-1 potentially had effects on the CV system was published in 2002, and the first study to show cardioprotection was in 2008 (102, 211), but it was not until the LEADER cardiovascular outcomes trial (CVOT) with liraglutide, published in 2016, that a reduction in CV risk with a GLP-1RA was documented (100)
Pulse shape: Whether a single administration creates the kind of temporal response the study is designed to observe
Inositol is involved in signaling hormones such as TSH, insulin, and gonadotropins
Other serums or treatments: If using additional serums (such as vitamin C or niacinamide), wait 23 minutes after your GHK-Cu serum before applying